Related Experiment Video
Updated: Aug 10, 2025
08:04
Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells In Vitro
Published on: March 18, 2014
12.9K
Macrophage Repolarization as a Therapeutic Strategy for Osteosarcoma.
Namrata Anand1, Keng Hee Peh1, Jill M Kolesar1,2
1Department of Pharmacy Practice and Science, College of Pharmacy, University of Kentucky, Lexington, KY 40508, USA.
International Journal of Molecular Sciences
|February 11, 2023
Summary
Repolarizing M2 tumor-associated macrophages (TAMs) to M1 macrophages offers a novel anti-cancer strategy. This approach shows promise for treating osteosarcoma (OS), a complex bone cancer where immunotherapy is less effective.
Area of Science:
- Immunology
- Oncology
- Cancer Research
Background:
- Macrophages are immune cells with diverse functions, categorized as M1 (pro-inflammatory, anti-tumor) or M2 (anti-inflammatory, pro-tumor).
- Tumor-associated macrophages (TAMs), often M2-polarized, promote tumor growth, invasion, and metastasis.
- Osteosarcoma (OS) presents a complex tumor microenvironment, limiting the efficacy of current immunotherapies.
Purpose of the Study:
- To review recent strategies for repolarizing M2 macrophages to M1 phenotype.
- To explore the potential of M2-to-M1 macrophage repolarization as an anti-cancer approach for osteosarcoma treatment.
Main Methods:
- Literature review of studies employing M2-M1 repolarization techniques.
- Analysis of research focusing on macrophage polarization in the context of osteosarcoma.
Main Results:
- M2-M1 repolarization strategies are emerging as a promising therapeutic avenue.
- Targeting macrophage polarization could overcome limitations of current osteosarcoma treatments.
Conclusions:
- Repolarizing TAMs from M2 to M1 phenotype represents an innovative strategy against osteosarcoma.
- Further research into M2-M1 repolarization holds significant potential for advancing osteosarcoma therapy.
